BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $441,000 | +11.9% | 6,699 | -14.2% | 0.17% | +21.7% |
| Q2 2022 | $394,000 | -20.6% | 7,809 | +0.5% | 0.14% | -10.4% |
| Q1 2022 | $496,000 | -41.0% | 7,769 | -0.9% | 0.15% | -30.0% |
| Q4 2021 | $840,000 | +5.1% | 7,839 | +0.9% | 0.22% | +0.9% |
| Q3 2021 | $799,000 | +14.1% | 7,769 | -2.4% | 0.22% | +10.1% |
| Q2 2021 | $700,000 | -14.7% | 7,959 | -5.7% | 0.20% | -21.4% |
| Q1 2021 | $821,000 | -6.2% | 8,439 | +8.2% | 0.25% | -8.4% |
| Q4 2020 | $875,000 | +21.7% | 7,799 | +0.5% | 0.28% | +4.2% |
| Q3 2020 | $719,000 | +36.4% | 7,759 | +14.8% | 0.26% | +26.3% |
| Q2 2020 | $527,000 | – | 6,760 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |